{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:03:04Z","timestamp":1792000984496,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["R21AR084644"],"award-info":[{"award-number":["R21AR084644"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["R01AR078230"],"award-info":[{"award-number":["R01AR078230"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["R01AR086572"],"award-info":[{"award-number":["R01AR086572"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AR075042"],"award-info":[{"award-number":["P30AR075042"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI121135"],"award-info":[{"award-number":["R01AI121135"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD028576"],"award-info":[{"award-number":["S10OD028576"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG3HL147367"],"award-info":[{"award-number":["UG3HL147367"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL097088"],"award-info":[{"award-number":["R01HL097088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL152723"],"award-info":[{"award-number":["R01HL152723"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI149646"],"award-info":[{"award-number":["U19AI149646"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS076991"],"award-info":[{"award-number":["R01NS076991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL131471"],"award-info":[{"award-number":["P01HL131471"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymthe.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:17:37Z","timestamp":1757542657000},"page":"6379-6397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases"],"prefix":"10.1016","volume":"33","author":[{"given":"Yeon-Suk","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Chaugule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc","family":"DeSouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Gravallese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-3293","authenticated-orcid":false,"given":"Jae-Hyuck","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.09.008_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.008_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11926-016-0620-x","article-title":"Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis","volume":"18","author":"Stavre","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ymthe.2025.09.008_bib4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa1507247","article-title":"Baricitinib in Patients with Refractory Rheumatoid Arthritis","volume":"374","author":"Genovese","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.008_bib5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/art.30176","article-title":"Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymthe.2025.09.008_bib6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard.2006.068064","article-title":"Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab","volume":"66","author":"Nishimoto","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymthe.2025.09.008_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(16)00380-9","article-title":"Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial","volume":"388","author":"Porter","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.09.008_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.clinthera.2011.05.044","article-title":"Use of biologics in rheumatoid arthritis: current and emerging paradigms of care","volume":"33","author":"Curtis","year":"2011","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ymthe.2025.09.008_bib9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: a clinical perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.09.008_bib10","doi-asserted-by":"crossref","first-page":"38R","DOI":"10.1203\/PDR.0b013e31819dbd0a","article-title":"An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum","volume":"65","author":"McGonagle","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymthe.2025.09.008_bib11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41584-022-00797-1","article-title":"IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting","volume":"18","author":"Broderick","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib12","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1086\/302874","article-title":"Identification of a locus on chromosome 1q44 for familial cold urticaria","volume":"66","author":"Hoffman","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2025.09.008_bib13","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus","volume":"360","author":"Reddy","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.008_bib14","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.008_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1086\/302589","article-title":"Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44","volume":"65","author":"Cuisset","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2025.09.008_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.09.008_bib17","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","article-title":"De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases","volume":"46","author":"Aksentijevich","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymthe.2025.09.008_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","article-title":"The IL-1 family of cytokines and receptors in rheumatic diseases","volume":"15","author":"Dinarello","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/312458a0","article-title":"Cloning and expression of murine interleukin-1 cDNA in Escherichia coli","volume":"312","author":"Lomedico","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.09.008_bib20","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1073\/pnas.81.24.7907","article-title":"Nucleotide sequence of human monocyte interleukin 1 precursor cDNA","volume":"81","author":"Auron","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.008_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/343341a0","article-title":"Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist","volume":"343","author":"Eisenberg","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.09.008_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/343336a0","article-title":"Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor","volume":"343","author":"Hannum","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.09.008_bib23","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.09.008_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.09.008_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ni.2237","article-title":"Regulation of inflammasome signaling","volume":"13","author":"Rathinam","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib26","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2025.09.008_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108998","article-title":"Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases","volume":"35","author":"Zhou","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.09.008_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","article-title":"The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism","volume":"39","author":"Murphy","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.09.008_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0024-3205(99)00095-8","article-title":"Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists","volume":"65","author":"Watkins","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2025.09.008_bib31","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1073\/pnas.83.22.8749","article-title":"Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint","volume":"83","author":"Pettipher","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.008_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2249.1994.tb06517.x","article-title":"Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment","volume":"95","author":"van den Berg","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.191.2.313","article-title":"Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice","volume":"191","author":"Horai","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.09.008_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/1043-4666(92)90078-6","article-title":"Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans","volume":"4","author":"Granowitz","year":"1992","journal-title":"Cytokine"},{"key":"10.1016\/j.ymthe.2025.09.008_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.09.008_bib36","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/1529-0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S","article-title":"Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymthe.2025.09.008_bib37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.46497\/ArchRheumatol.2022.9819","article-title":"Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"37","author":"Ozdemirel","year":"2022","journal-title":"Arch. Rheumatol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib38","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/art.11389","article-title":"Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis","volume":"48","author":"Lories","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymthe.2025.09.008_bib39","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.M111023200","article-title":"Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter","volume":"277","author":"Korchynskyi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.09.008_bib40","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1101\/gad.13.16.2059","article-title":"ECSIT is an evolutionarily conserved intermediate in the Toll\/IL-1 signal transduction pathway","volume":"13","author":"Kopp","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2025.09.008_bib41","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1038\/s41467-022-33956-9","article-title":"Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.008_bib42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1517\/14712598.2012.681463","article-title":"The advent of AAV9 expands applications for brain and spinal cord gene delivery","volume":"12","author":"Dayton","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.008_bib43","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1096\/fj.14-269092","article-title":"Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates","volume":"29","author":"Mattar","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2025.09.008_bib44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/hum.2008.123","article-title":"Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat","volume":"19","author":"Bish","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.008_bib45","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.omtm.2020.04.010","article-title":"Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy","volume":"17","author":"Yang","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.09.008_bib46","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1038\/s41467-019-10809-6","article-title":"Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.008_bib47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/hum.2017.181","article-title":"Gene Delivery to Joints by Intra-Articular Injection","volume":"29","author":"Evans","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.008_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-1119(86)90346-X","article-title":"Activating elements in the promoter region of the chicken beta-actin gene","volume":"48","author":"Fregien","year":"1986","journal-title":"Gene"},{"key":"10.1016\/j.ymthe.2025.09.008_bib49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fimmu.2016.00213","article-title":"K\/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis","volume":"7","author":"Christensen","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","article-title":"From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins","volume":"10","author":"Korganow","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.09.008_bib51","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.33504","article-title":"Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway","volume":"64","author":"Matzelle","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymthe.2025.09.008_bib52","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426","author":"Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.09.008_bib53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.20041758","article-title":"A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice","volume":"201","author":"Yoshitomi","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.09.008_bib54","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI200421795","article-title":"Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice","volume":"114","author":"Hata","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.09.008_bib55","article-title":"Deficiency of interleukin-1 receptor antagonist in mice differentially affects bone properties under different genomic backgrounds","volume":"14","author":"Dong","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.09.008_bib56","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.93.20.11008","article-title":"Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice","volume":"93","author":"Hirsch","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.008_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035979","article-title":"Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice","volume":"7","author":"Bonar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.09.008_bib58","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.0803007","article-title":"The mechanism of osteoclast differentiation induced by IL-1","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib59","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":"Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine","volume":"38","author":"Ozen","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib60","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymthe.2025.09.008_bib61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2567.1996.d01-672.x","article-title":"Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells","volume":"88","author":"Drenth","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.ymthe.2025.09.008_bib62","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3899\/jrheum.111549","article-title":"Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study","volume":"39","author":"Nordstrom","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib63","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.09.008_bib64","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.09.008_bib65","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13018-023-03590-2","article-title":"Efficacy and safety of anti-interleukin-1 therapeutics in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Yu","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.ymthe.2025.09.008_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-med-061512-150641","article-title":"IL-1 blockade in autoinflammatory syndromes","volume":"65","author":"Jesus","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2025.09.008_bib67","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/41.9.972","article-title":"Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage","volume":"41","author":"Abramson","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.ymthe.2025.09.008_bib68","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymthe.2025.09.008_bib69","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.008_bib70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymthe.2020.01.007","article-title":"Encouraging and Unsettling Findings in Long-Term Follow-up of AAV Gene Transfer","volume":"28","author":"Herzog","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.008_bib71","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mt.2011.287","article-title":"The AAV vector toolkit: poised at the clinical crossroads","volume":"20","author":"Asokan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.008_bib72","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/art.10481","article-title":"C3-Tat\/HIV-regulated intraarticular human interleukin-1 receptor antagonist gene therapy results in efficient inhibition of collagen-induced arthritis superior to cytomegalovirus-regulated expression of the same transgene","volume":"46","author":"Bakker","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymthe.2025.09.008_bib73","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00296-012-2500-7","article-title":"SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes","volume":"33","author":"Keller","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ymthe.2025.09.008_bib74","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib75","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/annrheumdis-2020-219247","article-title":"SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models","volume":"80","author":"Hayer","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymthe.2025.09.008_bib76","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218019120","article-title":"Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis","volume":"120","author":"Stavre","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.008_bib77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.09.008_bib78","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2025.09.008_bib79","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:18:00Z","timestamp":1773127080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625007361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1525001625007361"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.008","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}